MedPath

Evening primrose oil

Generic Name
Evening primrose oil
Drug Type
Biotech
CAS Number
308064-97-3
Unique Ingredient Identifier
3Q9L08K71N

Overview

Evening primrose oil comes from the extraction from Oenothera biennis seeds and it is commonly used as an alternative source for omega-6 essential fatty acids. In its composition it presents some fatty acids such as Linolenic acid and Gamolenic acid. Evening primrose oil has been filled for the FDA by Humanetics Corporation on April 2000 to be a new dietary ingredient but its current status is "Inadequate basis for expectation of safety". By Health Canada, evening primrose oil is approved in over-the-counter combination dietary supplements. By the EMA, evening primrose oil is approved in herbal preparations.

Indication

Evening primrose oil is used as part of over-the-counter dietary supplements. It is also used for the treatment of systemic inflammatory diseases and for women's health conditions such as cyclical mastalgia. These indications do not have sufficient evidence of their effectiveness. It was used for the treatment of atopic dermatitis in the United Kingdom but it is currently withdrawn due to lack of evidence of effectiveness.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2009/10/22
Phase 4
Completed
Medical College and Hospital Kolkata

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
EFAMOL CAP
efamol research inc.
00551864
Capsule - Oral
.6 ML
12/31/1982
EVENING PRIMROSE OIL WITH VITAMIN E
ashbury research corporation
02240554
Capsule - Oral
500 MG / CAP
N/A
NAUDICELLE CAP
bio oil research ltd.
00511188
Capsule - Oral
552 MG / CAP
12/31/1981
OENOTHERA BIENNIS
dolisos canada inc.
02234636
Liquid ,  Granules ,  Globules - Oral
1 X
1/5/1998
NAUDICELLE OIL OF EVENING PRIMROSE
swiss herbal remedies ltd.
00515671
Capsule - Oral
552 MG / CAP
12/31/1981
EVENING PRIMROSE OIL CAP
nature's way of canada ltd.
00630578
Capsule - Oral
500 MG / CAP
12/31/1984
GAMMA OIL
quest vitamins a div of purity life health products
00650277
Capsule - Oral
500 MG / CAP
12/31/1985

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.